We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$321M
AUM Growth
+$58M
Cap. Flow
+$56.4M
Cap. Flow %
17.58%
Top 10 Hldgs %
57.18%
Holding
275
New
60
Increased
44
Reduced
12
Closed
150
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
76
Arcus Biosciences
RCUS
$3.64B
$275K 0.09%
8,041
TWTR
77
DELISTED
Twitter, Inc.
TWTR
$243K 0.08%
3,699
TNET icon
78
TriNet
TNET
$3.14B
$242K 0.08%
+2,499
New +$214K
COST icon
79
Costco
COST
$420B
$231K 0.07%
491
FRA icon
80
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
$228K 0.07%
17,078
-16,576
-49% -$221K
NOW icon
81
ServiceNow
NOW
$129B
$213K 0.07%
1,560
CMG icon
82
Chipotle Mexican Grill
CMG
$41.5B
$208K 0.06%
+5,700
New +$207K
MSCI icon
83
MSCI
MSCI
$40.9B
$201K 0.06%
322
FT
84
Franklin Universal Trust
FT
$197M
$104K 0.03%
+12,565
New +$106K
GUT
85
Gabelli Utility Trust
GUT
$559M
$99K 0.03%
12,749
+1,617
+15% +$12.7K
BKT icon
86
BlackRock Income Trust
BKT
$341M
$94K 0.03%
5,098
+675
+15% +$12.9K
TMO icon
87
Thermo Fisher Scientific
TMO
$220B
$13K ﹤0.01%
+22
New +$12.1K
ABT icon
88
Abbott
ABT
$187B
$12K ﹤0.01%
99
-26
-21% -$3.19K
DHR icon
89
Danaher
DHR
$144B
$12K ﹤0.01%
+44
New +$12K
EW icon
90
Edwards Lifesciences
EW
$51.7B
$12K ﹤0.01%
+105
New +$12K
ISRG icon
91
Intuitive Surgical
ISRG
$134B
$12K ﹤0.01%
+36
New +$12.1K
PFE icon
92
Pfizer
PFE
$153B
$12K ﹤0.01%
+280
New +$12.4K
BNTX icon
93
BioNTech
BNTX
$23.5B
$10K ﹤0.01%
+38
New +$12.1K
REGN icon
94
Regeneron Pharmaceuticals
REGN
$80.8B
$10K ﹤0.01%
16
-2
-11% -$1.24K
A icon
95
Agilent Technologies
A
$41.2B
$7K ﹤0.01%
+46
New +$7.44K
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$126B
$7K ﹤0.01%
+40
New +$7.81K
WST icon
97
West Pharmaceutical
WST
$24.9B
$5K ﹤0.01%
+11
New +$4.64K
LH icon
98
Labcorp
LH
$25.9B
$4K ﹤0.01%
+17
New +$4.28K
BIO icon
99
Bio-Rad Laboratories Class A
BIO
$9.42B
$3K ﹤0.01%
+4
New +$3K
COO icon
100
Cooper Companies
COO
$14.5B
$3K ﹤0.01%
+28
New +$2.99K

Similar funds

Anfield Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Anfield Capital Management held 275 positions worth $321M, up 22% from $263M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Anfield Capital Management deployed $56.4M of net new capital in Q3 2021, opening 60 new positions and adding to 44 existing holdings. Its largest new stake was Invesco QQQ Trust: 31,422 shares worth $11.2M.

By sector, the portfolio is most concentrated in Financials at 2.9% of assets, up from 2.9% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was BlackRock Floating Rate Income Strategies Fund, an estimated $221K trimmed.

  • Anfield Capital Management's largest Q3 2021 buy was Invesco QQQ Trust: 31,422 shares worth $11.2M.
  • Anfield Capital Management added most to iShares US Treasury Bond ETF in Q3 2021, an estimated $3.16M increase.
  • Anfield Capital Management's biggest Q3 2021 reduction was BlackRock Floating Rate Income Strategies Fund, cutting an estimated $221K.
  • Anfield Capital Management fully exited Anfield Dynamic Fixed Income ETF in Q3 2021, selling an estimated $2.83M.
  • Anfield Capital Management's ten largest holdings make up 57% of its $321M portfolio in Q3 2021.
  • Anfield Capital Management opened 60 new positions and closed 150 in Q3 2021.
  • Anfield Capital Management's portfolio value rose 22% quarter-over-quarter to $321M.

Based on Anfield Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.